Genetron Health is a prominent precision oncology platform in China, specializing in cancer molecular profiling through advanced technologies in molecular biology and data science. The company has developed a comprehensive oncology portfolio that encompasses the entire cancer management spectrum, including early screening, diagnostics, treatment recommendations, continuous disease monitoring, and biopharma development services. Their innovative One-Step Seq Method and Mutation Capsule are key technologies that enhance clinical management by enabling the detection of unique gene mutations, assisting in targeted drug selection, and evaluating immunotherapy efficacy. Genetron Health's capabilities extend to a wide range of cancers, including lung, digestive tract, thyroid, and central nervous system cancers, supported by extensive research and partnerships with leading institutions.

The company's diagnostic solutions utilize various methods such as fluorescent quantitative PCR, digital PCR, and next-generation sequencing (NGS) to provide precise molecular diagnostics. Their product offerings include a range of in vitro diagnostic (IVD) products and laboratory-developed tests (LDTs) that cater to both tissue and liquid biopsies. Genetron Health's platforms, such as the GENETRON S5 and S2000 high-throughput sequencing systems, facilitate efficient and accurate sequencing processes, while their automated systems streamline sample preparation. By focusing on user-centered care and leveraging global R&D resources, Genetron Health aims to deliver comprehensive solutions that address the needs of patients, healthcare providers, and pharmaceutical companies throughout the cancer care continuum.

China

Genetron Holdings Limited ("Genetron Health" or the "Company")  is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care.

Genetron Health

Company Details